APA (7th ed.) Citation

I, J., JE, G., J, S., EK, K., Y, H., DJ, W., . . . GL, G. (2024). Adalimumab serum levels and anti-drug antibodies: Associations to treatment response and drug survival in inflammatory joint diseases. Rheumatology (Oxford, England), 63(6), 1746. https://doi.org/10.1093/rheumatology/kead525

Chicago Style (17th ed.) Citation

I, Jyssum, et al. "Adalimumab Serum Levels and Anti-drug Antibodies: Associations to Treatment Response and Drug Survival in Inflammatory Joint Diseases." Rheumatology (Oxford, England) 63, no. 6 (2024): 1746. https://doi.org/10.1093/rheumatology/kead525.

MLA (9th ed.) Citation

I, Jyssum, et al. "Adalimumab Serum Levels and Anti-drug Antibodies: Associations to Treatment Response and Drug Survival in Inflammatory Joint Diseases." Rheumatology (Oxford, England), vol. 63, no. 6, 2024, p. 1746, https://doi.org/10.1093/rheumatology/kead525.